Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective?

Abstract

Under favorable conditions, general screening by endoscopy of all patients with reflux symptoms to prevent death from esophageal adenocarcinoma may represent a cost-effective strategy; however, such conditions may be difficult to meet.